Medicine prices soaring in Pakistan; patients, healthcare professionals warn of affordability crisis amid inflation and rising operational costs.

A sharp rise in medicine prices across Pakistan is triggering growing concern among patients, healthcare professionals, and consumer rights groups. The cost of essential drugs has continued to climb amid inflationary pressure and rising operational costs, leading to an escalating affordability crisis. From diabetes and blood pressure medicines to antibiotics, flu treatments, eye drops, and cardiac drugs, patients are increasingly struggling to afford routine healthcare needs.

According to healthcare observers and market reports, the prices of several commonly used medicines have surged by more than 200% over recent months. Pharmaceutical companies have reportedly implemented repeated price increases due to factors such as rising fuel costs, import expenses, and economic instability impacting the healthcare supply chain. The rising costs are particularly affecting patients suffering from chronic illnesses like diabetes, hypertension, and heart disease, many of whom rely on continuous medication for survival and long-term treatment management.

Medical professionals warn that growing financial pressure is forcing some patients to delay treatment, reduce prescribed dosages, or avoid purchasing medicines altogether - a trend experts say could lead to worsening health complications and increased hospitalizations in the future. Among the medicines witnessing major price jumps are insulin products, antibiotics, cough syrups, calcium supplements, vitamin injections, allergy medicines, and skin treatments.

Consumer rights groups and public health advocates are now urging the government and the Drug Regulatory Authority of Pakistan (DRAP) to strengthen oversight, improve transparency in pharmaceutical pricing, and ensure the availability of affordable essential medicines across the country. With inflation already impacting food, fuel, and utility costs, the continued rise in medicine prices is adding another layer of economic and emotional stress for millions of households dependent on long-term medical treatment.